| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 12/12/2007 | CN100354425C Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines |
| 12/12/2007 | CN100354277C 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 12/12/2007 | CN100354273C Novel substituted 4-phenyl-4-ú¿1h-imidazol-2-ylú®-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 12/12/2007 | CN100353953C Traditional Chinese medicina preparation for treating oral cavity, throat disease and its preparation method |
| 12/11/2007 | US7307090 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 12/11/2007 | US7307079 Treating acute and chronic pain and inflammatory, gastrointestinal, allergic, cardiovascular, skin, opthalmological, respiratory, nervous system, cognition and memory disorders, etc. |
| 12/11/2007 | US7306792 In particular, invention relates to alphavirus-based, preferably Sindbis virus-based, vectors and to non-alphavirus-based vectors, which have a preferential affinity for high affinity laminin receptors |
| 12/11/2007 | US7306787 Engineered particles and methods of use |
| 12/11/2007 | CA2348735C Heterocyclic potassium channel inhibitors |
| 12/06/2007 | WO2007140117A1 Compounds and compositions as channel activating protease inhibitors |
| 12/06/2007 | WO2007139240A1 7-(3,4-dialkoxyphenyl)-pyrazolo[1,5-a]pyrimidine compounds, process for preparing thereof, and pharmaceutical composition for treating or preventing asthma, chronic obstructive pulmonary disease, arthritis, atopic dermatitis, tumor and degenerative brain diseases comprising the same |
| 12/06/2007 | WO2007139230A1 Seven-membered ring compound, production method thereof and pharmaceutical use thereof |
| 12/06/2007 | WO2007139153A1 Function-improving agent for cerebral dysfunction caused by environmental chemical |
| 12/06/2007 | WO2007138994A1 Hsp90 inhibitor |
| 12/06/2007 | WO2007138993A1 Method for culture of lactic acid bacterium having high immunomodulating activity |
| 12/06/2007 | WO2007138961A1 Prophylactic or therapeutic agent for disorder induced by macrophage migration inhibitory factor |
| 12/06/2007 | WO2007138282A2 Bi-aryl or aryl-heteroaryl substituted indoles |
| 12/06/2007 | WO2007138225A1 Composition for controlling snoring, in the form of a nasal spray |
| 12/06/2007 | WO2007138224A1 Nasal and buccal compositions for controlling snoring |
| 12/06/2007 | WO2007137369A1 Medicinal compositions containing honey |
| 12/06/2007 | WO2007107828A3 Amine derivatives |
| 12/06/2007 | WO2007105053A3 Tetralines antagonists of the h-3 receptor |
| 12/06/2007 | WO2007087215A3 N-acetyl-cysteine and its derivatives as an antitussive |
| 12/06/2007 | WO2007080174A3 Chimeric and humanised anti-human il-13 antibodies |
| 12/06/2007 | US20070282126 Novel Crystal Of Triterpene Derivative |
| 12/06/2007 | US20070282105 e.g. 3-[2-(4-aminophenyl)ethyl]-8-benzyl-7-(2-ethylamino)ethyl-1-propylxanthine; A1-adenosine receptor antagonist; antiallergen, antiinflammatory agent; AIDS and immune deficiency disorders, asthma; good water solubility |
| 12/06/2007 | US20070282100 Boronic ester and acid compounds, synthesis and uses |
| 12/06/2007 | US20070281933 Novel Indazole Carboxamides And Their Use |
| 12/06/2007 | US20070281893 Polysulfated Glycosides And Salts Thereof |
| 12/06/2007 | US20070281036 System and method of delivering a desired material to a cell |
| 12/06/2007 | US20070281005 Administering zonisamide; clearing mucus; protective patches |
| 12/06/2007 | US20070280958 homodimer-forming chemokines such as Chemokine (C-C motif) ligand 2 (CCL2) having a single amino acid substitution in the dimerization interface that alters the pattern of hydrogen bonds; for inflammatory, autoimmune, or infectious diseases |
| 12/06/2007 | US20070280931 Antibody variants |
| 12/06/2007 | US20070280886 Diagnostics and Therapeutics for Diseases Associated with Adrenomedullin Receptor (Amdr) |
| 12/06/2007 | CA2653920A1 Composition for controlling snoring, in the form of a nasal spray |
| 12/06/2007 | CA2653916A1 Nasal and buccal compositions for controlling snoring |
| 12/06/2007 | CA2653667A1 7-membered ring compound and method of production and pharmaceutical application thereof |
| 12/06/2007 | CA2653319A1 Hsp90 inhibitor |
| 12/06/2007 | CA2652044A1 Pyrrolopyrimidine compounds and their uses |
| 12/06/2007 | CA2651043A1 Compounds and compositions as channel activating protease inhibitors |
| 12/05/2007 | EP1862451A1 Adamantane derivatives for the treatment of inflammatory diseases |
| 12/05/2007 | EP1861388A1 Potassium channel modulating agents and their medical use |
| 12/05/2007 | EP1861372A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 12/05/2007 | EP1861371A1 Novel compounds ii 2-pyridine derivatives as inhibitors of neutrophile elastase. |
| 12/05/2007 | EP1861370A1 2-pyridine derivatives as inhibitors of neutrophile elastase |
| 12/05/2007 | EP1861361A1 Glycopyrronium salts and their therapeutic use |
| 12/05/2007 | EP1861092A1 Potassium channel opener having benzofuroindole skeleton |
| 12/05/2007 | EP1861074A1 Taste masked dosage form containing roflumilast |
| 12/05/2007 | EP1861072A2 Nanocells for diagnosis and treatment of diseases and disorders |
| 12/05/2007 | EP1663197B1 The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma |
| 12/05/2007 | EP1492876B1 Cationic amphiphiles for intracellular delivery of therapeutic molecules, composition, process and use thereof |
| 12/05/2007 | EP1485359B1 Sodium channel blockers |
| 12/05/2007 | EP1399420B1 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 12/05/2007 | EP1305329B1 6.alpha.,9.alpha.-difluoro-17.alpha.-(2-furanylcarboxyl)oxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 12/05/2007 | EP1173252B1 Products for brachytherapy and methods for their production |
| 12/05/2007 | CN101081834A Process for the preparation of leukotriene antagonists |
| 12/05/2007 | CN101081296A Method for preparing b type haemophilus influenzae capsular polysaccharide and united vaccines thereof |
| 12/05/2007 | CN101081255A kazukiyo oral liquid agent and its preparing process |
| 12/05/2007 | CN101081253A Chinese medicinal materials preparations for treating rheum |
| 12/05/2007 | CN101081247A Bag infusion for drinking and for smoking to treat nose disease |
| 12/05/2007 | CN101081246A Medicine for treating pharyngitis |
| 12/05/2007 | CN101081224A Stable extended release oral dosage composition |
| 12/05/2007 | CN101081223A Application of 2, 2'-bipyridine N- oxide disulfide in the preparing of antiphlogistic medicine |
| 12/05/2007 | CN101081212A Protease inhibitors liposomes aerosol |
| 12/05/2007 | CN101081092A beverage for expelling toxin and treating melancholy |
| 12/05/2007 | CN101081075A Selenium germanium peptide jujube tea paste for effecting radical cure of tuberculosis, slow and fume |
| 12/05/2007 | CN100352923C Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 12/05/2007 | CN100352840C Nucleus factor-kB p50 subunit combination peptide, preparation and application thereof |
| 12/05/2007 | CN100352816C Nociceptin analogs |
| 12/05/2007 | CN100352807C Chemical compounds |
| 12/05/2007 | CN100352806C 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
| 12/05/2007 | CN100352804C 酰胺衍生物 Amide derivatives |
| 12/05/2007 | CN100352507C Osmotic pump controlled release formulation containing two active constituents of medicine and process for preparing the same |
| 12/05/2007 | CN100352500C Stable liquid formulations of antibodies |
| 12/05/2007 | CN100352495C Stabilized pharmaceutical composition in lyophilized form |
| 12/05/2007 | CN100352467C Chinese medicinal composition for treating upper respiratory tract infection |
| 12/05/2007 | CN100352462C Rhinitis treating ointment |
| 12/05/2007 | CN100352460C Effervescent tablet used for treating respiration, circulation system disease, its preparation method and quality control method |
| 12/05/2007 | CN100352452C Application of Chinese medicine starfish in preparation of medicament for treating rhinitis |
| 12/05/2007 | CN100352448C Methods and compositions for the prevention of tolerance to medications |
| 12/05/2007 | CN100352435C Dry syrup preparation of procaterol comprising ascorbinic acid and citric acid |
| 12/05/2007 | CN100352433C Fatty alcohols and fatty acid esters useful for treatment of inflammation |
| 12/04/2007 | US7304083 2-iminoimidazole derivatives (2) |
| 12/04/2007 | US7304077 Asthma, rhinitis therapy |
| 12/04/2007 | US7304072 Spiro compounds |
| 12/04/2007 | US7304070 eg 8-(4-{[3-(2-methylphenyl)(1,2,4-oxadiazol-5-yl)]methoxy}phenyl)-1,3-dipropyl-1,3,7-trihydropurine-2,6-dione; atherosclerosis, angiogenesis, diabetic retinopathy, cancer, asthma, diarrhea, senile dementia, Alzheimer's disease, or Parkinson's disease |
| 12/04/2007 | US7304066 Pyridyl cyanoguanidine compounds |
| 12/04/2007 | US7304064 1-[(indol-3-yl)carbonyl]piperazine derivatives |
| 12/04/2007 | US7304060 Enzyme inhibitors for antidiabetic agents, antitumor disorders, treatment of skin disorters, anticancer agents and cognitive activators for Alzheimers disease treatment |
| 12/04/2007 | US7304059 Substituted quinazolin-4-ylamine analogues |
| 12/04/2007 | US7303885 For treating or detecting MIF (macrophage migration inhibitor factor) related diseases by detecting MIF/Jab1 (c-Jun activation domain binding protein) interactions; complex MIF in natural association with Jab1 and optionally another protein |
| 12/04/2007 | CA2255891C Compositions and methods for treating or preventing diseases of body passageways |
| 12/04/2007 | CA2223894C Dinucleotides useful for the treatment of lung disease |
| 12/04/2007 | CA2212205C Use of xanthine derivatives for the modulation of apoptosis |
| 12/04/2007 | CA2169608C Medical gas mixture |
| 11/29/2007 | WO2007137080A2 Compounds and compositions as channel activating protease inhibitors |
| 11/29/2007 | WO2007135409A1 Particulate drug and drug compositions and their uses |
| 11/29/2007 | WO2007135195A1 Ectonucleotidase inhibitors |
| 11/29/2007 | WO2007135081A1 Histamine receptor antagonists comprising an azepin core |
| 11/29/2007 | WO2007135080A2 (2r)-2-[(4-sulfonyl)aminophenyl]propanamides and pharmaceutical compositions containing them |